1. Introduction {#sec1}
===============

*Repairing and Renewing the Brain from the Inside*. Brain development implicates cell migration, differentiation, and plasticity to configure an efficient neuronal network. While neurons can live long periods of time, a large number of neurons die during developmental and pathophysiological processes in a lifetime. The loss of neurons in adulthood can lead to nervous system disorders such as neurodegenerative diseases, which involve cognitive and motor alterations causing severe disability and generally death. While pharmacological treatment for this kind of diseases may attenuate symptoms and disease progression at initial stages, pharmacological efficacy gradually decreases over time \[[@B46]\]. New experimental approaches must be developed to design efficacious therapies for repairing and renewing the neuronal network to restore lost functions in order to expand possibilities of cures for brain diseases.

Neural stem cells (NSCs) can generate different types of neurons. In order to generate sensory neurons, motor neurons, or interneurons, NSCs in adequate microenvironment must receive cellular context-specific molecular signals to determine fate and location. These newly formed neurons establish new circuits and modify existing pathways connecting neuron to neuron. In this context, NSC graft appears to be a promising strategy to recover lost functions due to neurons death in the brain. Unfortunately, neural grafts have not been as successful as expected, due to poor survival of grafted cells and the inability of surviving cells to connect with central network \[[@B8], [@B22]\]. The control of stem cells differentiation into specific types of neurons as well as their survival and connectivity may enable the establishment of a renewal supply to replace dead or damaged neurons. Recently, the controlled expression of the nonselective cationic channel TRPV1, which is widely expressed in peripheral and central nervous system \[[@B10]--[@B91]\], has proven effective on the control of many functions in brain neurons \[[@B2]--[@B62]\]. The regulated activity of TRPV1 promotes migration \[[@B94]\], axon growth \[[@B28]\], cell-to-cell extension \[[@B26]\], and release of neurotransmitters (GABA, dopamine, and glutamate) \[[@B57], [@B54]\], and more interestingly a novel function has been reported which is the ability to control brain neurogenesis \[[@B2], [@B40], [@B83]\]. In addition, the regulated activation of the channel is also involved in cell resistance against local oxidative environment in brain regions and other tissues \[[@B30], [@B67]--[@B70]\].

In this review we explore the contribution of TRPV1 channel function in NSC fate, discussing possible roles of the channel in neurogenesis and network integration, and eventually we propose the use of TRPV1 control as a new clinically promising strategy to improve the plasticity of newborn neural network derived from grafted neural precursors in the damaged brain.

2. Polymodal TRPV1: An Environmental Signal Integrator {#sec2}
======================================================

Transient receptor potential ion channel (TRP) family consists of a number of nonselective cationic channels capable of integrating environmental physicochemical signals and coupling their activity to downstream amplification of cellular signal through cation permeation and membrane depolarization \[[@B10], [@B91], [@B17]--[@B81]\]. In cellular context, the activity of TRPs is modulated by several molecular mechanisms such as phosphorylation, reactive oxygen species (ROS), membrane lipid composition, intracellular calcium, and ATP levels \[[@B90], [@B81]--[@B99]\]. Among the six members (TRPV1-6) of TRPV (vanilloid) subfamily, TRPV1 was the first identified and best characterized \[[@B90], [@B11]\]. TRPV1 is a homotetrameric nonselective cation channel (*P* ~Ca~/*P* ~Na~ = 9.6) with the same characteristics as other TRPs \[[@B45]\]. It is activated by several physical stimuli such as temperature, voltage, protons, osmolarity, pH \[[@B10], [@B65], [@B11]\], chemical ligands such as PIP~2~ or endocannabinoids like anandamide, and exogenous ligands as resiniferatoxin and capsaicin \[[@B11], [@B9], [@B75]\] ([Figure 1(a)](#fig1){ref-type="fig"}).

New evidence links a specific hydrophobic pocket near the S5 helix that contains amino acids R579, F582, and L585 to the binding of PIP~2~ \[[@B73]\] and cholesterol \[[@B71]\] ([Figure 1(b)](#fig1){ref-type="fig"}). The binding of these two molecules to the hydrophobic pocket may either potentiate or inhibit TRPV1 activity. More interestingly, the *α*-3-OH diastereoisomer of cholesterol epicholesterol has no effects on TRPV1-mediated currents, suggesting the existence of a stereospecific binding site \[[@B71]\]. 17*β*-Estradiol increases currents evoked by capsaicin in dorsal root ganglion neurons \[[@B16]\] and capsaicin-induced nociception, whereas these capsaicin effects are reduced by testosterone \[[@B47]\]. Thus, modification of TRPV1 hydrophobic environment may alter its biophysical properties and contribute to functional coupling. Several mechanisms show intrinsic cooperative regulation, suggesting allosteric modulation of these ion channels, although there is no definite evidence on the potential binding site. It is noticeable that, in particular context, TRPV1 could work as ionotropic receptor of cholesterol-derived molecules with opposite actions. This feature allows them to act as signal integrators \[[@B73]\], playing critical roles in excitable and nonexcitable cell functions underlying sensory physiology, proliferation, growth, male fertility, and neuronal plasticity \[[@B59], [@B7]--[@B64]\].

3. TRPV1 in the Brain {#sec3}
=====================

TRPV1 was first described in peripheral afferent fibers and identified as a detector of harmful signals in primary sensory neurons \[[@B11]\]. The currently known distribution of TRPV1 includes testis, heart, lung, stomach, and brain \[[@B90], [@B14], [@B5]--[@B92]\]. Particularly, in peripheral nervous system (PNS) TRPV1 is highly expressed in dorsal root ganglia (DRG), trigeminal ganglia, and primary sensory neurons, which are sensory neuronal components of nociceptive A*δ* and C-fibers\' circuits \[[@B10], [@B90]\]. In PNS TRPV1 was primarily studied for its anti-inflammatory and antinociceptive functions \[[@B68], [@B11], [@B64]\], but currently a more general function has been attributed to TRPV1; this is an integrator of several noxious stimuli such as low pH (pH \< 6.0) or high temperature (\>43 degrees Celsius) \[[@B1]\]. In central nervous system (CNS) the expression of TRPV1 is still controversial. Whereas some seminal reports showed very low or no expression of the channel in CNS \[[@B11], [@B85]\], recent reports have shown (1) that well-recognized endogenous activators such as N-arachidonoyldopamine (NADA) or exogenous activators such as capsaicin (CAP) or even potent TRPV1-specific inhibitors like capsazepine (CPZ) or resiniferatoxin (I-RTX) can modulate the activity of neurons in CNS \[[@B30], [@B14], [@B12], [@B102]\] and (2) direct evidence on the expression of TRPV1 by immunohistochemistry, PCR, autoradiography, and*in situ* hybridization in mammalian brain \[[@B18], [@B88], [@B56], [@B58]\]. The amount of expression of TRPV1 differs importantly between central and peripheral nervous system. In the brain, it is 20- to 30-fold lower than in DRG \[[@B11], [@B32]\]. The poor TRPV1 expression in CNS has demanded greater precision and refinement of experimental methods in order to increase the reliability of localization of the channel in the brain and its significance. In addition, the existence of TRPV1 alternates which are heterogeneously distributed throughout the nervous system \[[@B77]\] complicates the interpretation of the results from several expression studies. However, a remarkable study using mice with genetically modified TRPV1 reporter protein along with other techniques such as*in situ* hybridization, calcium-imaging, RT-PCR, and slice electrophysiological recordings provided definite evidence on the expression of functional TRPV1 in primary afferent neurons while low levels of expression were found in entorhinal cortex, olfactory bulb, hippocampus, and hypothalamus \[[@B12]\], which are nevertheless active enough to modulate excitability in hypothalamus \[[@B12]\]. More intriguingly, TRPV1 can be transiently expressed during brain development. In some brain regions the expression can suffer postnatal restriction depending on age, physiological, or pathological condition \[[@B56]\], suggesting that TRPV1 functional expression might be modulated by the metabolic cell state.

The number of reports addressing the functional effect of activation/suppression of TRPV1 channel expressed in several brain regions increases each year. To date, both TRPV1 mRNA and protein have been found mainly in cortical structures and hippocampal pyramidal neurons in areas CA1, CA3, and dentate gyrus but have also been found in the locus coeruleus, cerebellum, thalamic and hypothalamic nuclei, periaqueductal grey, and limbic structures including the caudate putamen, the central amygdala, and the substantia nigra pars compacta \[[@B18], [@B56], [@B42]\]. With regard to the cell type where TRPV1 is expressed, it has been reported in different lineages, most commonly neurons. For instance, in hippocampal dentate gyrus many pyramidal neurons throughout the CA1--CA3 areas express TRPV1 receptor on cell bodies. In thalamus, TRPV1 expression has been found in neuronal cytoplasmic and axonal staining; in cerebellum TRPV1 channels surround several Purkinje cell bodies, especially on basal areas corresponding to the initial axonal segment; in cortex the expression also surrounds the nucleus; and in substantia nigra double labelling immunofluorescence shows a complete overlap between TRPV1 and tyrosine hydroxylase, confirming the presence in dopaminergic neurons \[[@B18], [@B58], [@B38]\]. We assayed our experimental strategy to identify the expression of TRPV1 by immunofluorescence in heterologous system and in neurons of primate prefrontal cortex, confirming the expression of TRPV1 in neurons and glia in mammalian brain ([Figure 2](#fig2){ref-type="fig"}).

4. TRPV1 Expression in Neural Progenitors {#sec4}
=========================================

Recent publications add a novel cell lineage to the vast list of cell types that express this channel in the brain. TRPV1 is expressed in neurogenic brain regions, in particular, in the hippocampal dentate gyrus subgranular zone (SGZ) as well as the subventricular zone in telencephalon (SVZ). In adult rat, TRPV1 is colocalized with nestin, a marker of NSCs. Since postnatal neurogenesis occurs up to day 21 and declines afterwards in mice, the expression of TRPV1 was measured in postnatal days 7, 14, 21, and 39, being positive at the time points that corresponded to the time course of postnatal neurogenesis p7, p14, and p21. More interestingly, TRPV1 was no longer detected from p39, when postnatal neurogenesis had declined \[[@B83]\]. Additionally to the expression of TRPV1 detected in early neural precursors, stimulating neurogenesis by exercise paradigm upregulates TRPV1 expression above baseline in the adult hippocampus \[[@B83]\]. In the same line, we induced*in vitro* differentiation of monkey embryonic stem (ES) cells to neural precursor and explored the expression of TRPV1 at different stages of differentiation. We used the LYON-ES1 cell line that stably expresses Tau-GFP, isolated at SBRI (Stem Cell and Brain Research Institute, INSERM, France). The primate pluripotent markers-expressing LYON-ES1 cells \[[@B96]\] are indefinitely self-renewable and have the capability of multilineage differentiation \[[@B96], [@B97]\]. We examined the expression of TRPV1 in LYON-ES1 cells, NSCs, glial cells, and neurons derived from LYON-ES1 cells. We used Pax6 as a marker for NSCs, *β*-III-tubulin, and glial fibrillary acidic protein (GFAP) as markers for neurons and glial cells \[[@B96], [@B97]\], respectively. We found that TRPV1 was expressed in NSCs ([Figure 3](#fig3){ref-type="fig"}) with cytoplasmic signal accompanied by a nuclear mark ([Figure 3](#fig3){ref-type="fig"}), as described previously \[[@B58], [@B6], [@B27]\]. In contrast, we did not detect TRPV1 in pluripotent stem cells, neurons, or glial cells.

The expression of TRPV1 has also been characterized in specific regions of the brain as previously mentioned \[[@B54], [@B14], [@B88]\], with particular microenvironment or extracellular pathways engaged in neurogenesis. The expression of TRPV1 in NSCs was evident in all experiments supporting the*in vivo* results previously reported \[[@B83]\].

Up until now, the TRPV1 expression pattern in neural precursors and its role in neurogenesis have been poorly studied and a new field on TRPV1 research is open with interesting implications in tissue regeneration.

5. TRPV1 Functions in the Brain {#sec5}
===============================

The function of TRPV1 in the brain has been subjected to exhaustive investigation, because of the multiple places where it has been detected, its sensitivity to different chemical and physical agonists, and its versatility as calcium channel. The intracellular calcium concentration modulated by TRPV1 is capable of triggering various processes such as excitability, proliferation, synaptic plasticity, resistance to oxidative stress, and cell death, depending on the concentration, timing, and transience of the signal \[[@B42], [@B63]\].

The most studied aspect of TRPV1 function relates to its activity on synaptic plasticity and excitability in the brain. The control of TRPV1 activity has proven effective to modulate the excitability in neurons \[[@B3]--[@B61]\]. In particular, peripheral nerve endings increase glutamate release following the activation of TRPV1 by heat \[[@B11]\]. Capsaicin, NADA, and endocannabinoids increase release of neurotransmitter in the central nervous system, the basal ganglia, hypothalamus \[[@B57], [@B62], [@B24]\], and cranial visceral afferent terminals in caudal solitary tract nucleus (NTS), in brainstem \[[@B80]\]. TRPV1 is involved in hippocampal long-term potentiation (LTP) \[[@B55]\] and depression (LTD) mediated, respectively, by vanilloids and endocannabinoids like anandamide \[[@B14], [@B24]\]. In addition, it could induce release of GABA in dentate gyrus depressing excitatory synaptic transmission \[[@B13]\]. Lastly, in the neighboring ventral tegmental area, capsaicin also increased the firing rate of dopamine neurons \[[@B54]\] as it did in excitatory synapses in the substantia nigra. Facilitated spontaneous excitatory postsynaptic current frequency by capsaicin and NADA without affecting amplitude suggested a presynaptic mechanism \[[@B52], [@B53]\].

TRPV1 has recently been demonstrated to have an important role in the regulation of cortical excitability by modulation of synaptic transmission in the human brain \[[@B61]\]. It would be interesting to understand how several physical and chemical activators or modulators interact to enhance or inhibit TRPV1 activity, because an allosteric coupling has been demonstrated with distinct agonist, increasing the effect of the channel activation and stimulating neuroplasticity \[[@B9], [@B73], [@B71]\].

6. TRPV1 and Neurogenesis {#sec6}
=========================

Spontaneous calcium oscillations play an important role in nervous system development, neural induction, axon guidance, growth cone morphology, migration, and proliferation \[[@B26], [@B43]--[@B95]\]. These oscillations are a combination of extracellular influx mediated by ionic channels and release of intracellular store from endoplasmic reticulum and/or mitochondria. TRP channels like TRPC and TRPV family have been related to control of neuronal differentiation and activity in CNS. TRPC channels mediate cortical neural precursor proliferation induced by bFGF \[[@B23]\] and TRPV1 differentiation triggered by retinoic acid \[[@B2]\] and rimonabant \[[@B40]\]. These two families also modulate the excitability in well-differentiated neurons and their precursors.

The first signs that linked TRPV1 with neurogenesis were indirect; in transiently transfected F11 cells and embryonic DRG neurons that endogenously express the channel, it was localized in neurites and growth cones where it regulates motility \[[@B26]\]. Dynamic processes such as growth cone motility and the direction of neurites involve calcium signals via cell surface receptors. The guidance of developing axons requires an active growth cone, and a localized calcium signal in the growth cone is sufficient for both attraction and repulsion \[[@B101]\]. TRPV1 located in the growth cone has been involved in the formation of filopodia in neurons \[[@B26]\]. In addition, TRPV1 contributes to cytoskeleton reorganization \[[@B25]\], cell migration \[[@B94]\], and regeneration of injured neurons \[[@B6]\].

These early discoveries indicate a key role of TRPV1 during neuronal differentiation. More specifically, TRPV1-expressing SHSY5Y neuroblastomas induced to differentiate by retinoic acid showed upregulation of total and cell surface TRPV1 protein expression. Specifically, these upregulated channels were localized in cell bodies and the new neurites. Besides, retinoic acid increased both the intracellular free calcium concentration and the relative calcium influx induced by capsaicin \[[@B2]\]. Moreover, rimonabant, an antagonist of cannabinoid receptor 1 (CB1), was evaluated as inducer of neurogenesis in dentate gyrus and subventricular zone (SVZ), expecting that the inhibition of CB1 triggered the generation of neurons \[[@B40]\]. Neurogenesis was increased in both wild-type and knockout mice for CB1, but the neurogenesis-promoting effect of rimonabant disappeared in TRPV1 knockout mice \[[@B40]\]. Until now the mechanisms remain unexplored, although the interaction of rimonabant and TRPV1 has been associated with other processes as neural cell survival in a global cerebral ischemia model \[[@B70]\]. The hypothesis is that the quick activation of TRPV1 followed by desensitization could induce transient increase of calcium signal activating survival pathways and others associated with neurogenesis such as ERK pathway \[[@B40]\]. At least in the case of neuroprotection, the effect over TRPV1 appears to be direct since it is abolished by the application of CPZ \[[@B70]\].

These findings added evidence on the TRPV1 involvement in neurogenesis and the interaction between vanilloids and the endocannabinoid system during the generation of new neurons. However, in dentate gyrus and the subventricular zone, loss of TRPV1 expression promotes proliferation of neural precursors. The TRPV1 knockout mice exhibited substantial rise in postnatally proliferating cells in both stem cell niches, but lesser differentiation to neurons or glia \[[@B83]\]. The primary neural precursors originated from newborn TRPV1 knockout mice expressed stem cell genes like nestin or Sox2 and no differentiation markers for astrocytes (GFAP) or neurons (*β*-III-tubulin). Thus, the loss of TRPV1 in neural precursors disturbs differentiation and the growth potential. These data confirm the role of TRPV1 in orchestrating proliferation/differentiation of neural precursors, which has already been reported in other cell types.

Finally, another interesting and not well-understood function of TRPV1 is the control of cell death. Micromolar concentrations of capsaicin and acid solution (pH 5.5) induce a cytosolic calcium increase, mitochondrial membrane depolarization, ROS production, and cell death via TRPV1 activity \[[@B36]\]. In rat cortical neurons TRPV1 activation by capsaicin induces apoptotic cell death through L-Type Ca^2+^ channels, provoking Ca^2+^ influx, ERK phosphorylation, ROS production, and caspase-3 activation \[[@B79]\]. However, similar results have been reported for capsaicin without TRPV1 participation \[[@B48], [@B49]\] suggesting both dependent and independent effects of this vanilloid. TRPV1 knockout (KO) mice present a testis, brain, and heart phenotype much more susceptible to cell death by oxidative stress stimuli compared to wild-type mice \[[@B92], [@B60]\]. Pretreatment with capsaicin can prevent cell death induced by ischemia/reperfusion in lung in rabbits with concomitant diminishing of lipid peroxidation \[[@B93]\]. Besides, in hippocampus subjected to 10 min ischemia, CA1 neurons pretreated with capsaicin were less susceptible to cell death and the effect was inhibited with capsazepine antagonist of TRPV1. The use of rimonabant, the same compound that induces neurogenesis by TRPV1, as a postischemic treatment facilitated neuroprotection independent of CB1 receptor and inhibited by capsazepine. The same effect was measured in a model of temporary global cerebral ischemia by pretreatment with capsaicin in Mongolian gerbils \[[@B68]\]. The mechanism suggested involves a moderate increase in Ca^2+^ influx via TRPV1. This transitory influx may induce tolerance to subsequent calcium overload, preconditioning the response and inducing neuroprotection. However, capsaicin administrated 5 minutes after recirculation had no effect \[[@B68]\]. A possible explanation is that capsaicin and other pharmacological agonists of TRPV1 induce activation of the channel followed by acute desensitization. In the case of vanilloids, this could occur after the first 20 seconds following the addition of vanilloid compounds \[[@B89]\]. The molecular mechanism includes several pathways related with intracellular Ca^2+^ concentration. One of them is dependent on the balance between phosphorylation and dephosphorylation of TRPV1 triggered by Ca^2+^-calmodulin pathway. Moreover, the dephosphorylation of the amino acid Ser502 and Thr704 by CaMKII has been associated with desensitization of the channel \[[@B89]\]. On the other hand, it has been demonstrated that calcium may induce TRPV1-caveolar endocytosis and lysosomal degradation \[[@B78], [@B84]\]. Independently of the mechanisms, the controlled activity of this polymodal receptor (activation-desensitization) seems to be critical for the cellular homeostasis in oxidative environment, acting as a modulator of cell viability. The precise cellular mechanism underlying TRPV1 activation-modulating cell homeostasis and viability remains unclear. Current information on cell death relates the activation of TRPV1 with abnormal function of the mitochondria. Mitochondrial dysfunction is frequently observed in cell death induced by high doses of capsaicin through TRPV1 activation. A significant portion of calcium entering the cytoplasm after the activation of TRPV1 is accumulated by mitochondria. Uptake of calcium by DRG neurons rises up to 20-fold compared to controls in the presence of 1 *μ*M capsaicin, without observable cytotoxic effect; however, pretreatment with the mitochondrial uncoupler almost stopped capsaicin-dependent accumulation of calcium \[[@B19], [@B98]\]. Furthermore, TRPV1 expression diminishes the damage produced by high salt-diet in mouse heart compared to knockout maintaining the mitochondrial function \[[@B44]\]. Particularly, the controlled activation of TRPV1 induces an increase in expression of sirtuin 3, a protein that regulates the activity of Complex I, ATP production, and increases ROS clearance through deacetylation of Mn-SOD \[[@B86]\]. It seems that capsaicin activation of TRPV1 can prevent cardiac mitochondria dysfunction caused by high salt intake \[[@B44]\]. Apparently, the activity of TRPV1 is coupled to mitochondrial function, regulating the calcium buffering and the clearance of mitochondrial ROS \[[@B33]\]. The deregulated activation of TRPV1 by high doses of chemical activators, for instance, could induce cell death possibly mediated by overstimulation of mitochondrial function.

The control of differentiation and of cell death could become interesting targets in the regulation of survival in neural precursors. Intense neuronal activity or neurodegenerative diseases increase oxidative environment finely modulated through TRP-induced homeostatic stability \[[@B93]\]. Then, the control of TRPV ion channels expression and activity on neural progenitors could trigger efficient signaling crosstalk mechanisms in response to oxidative stress, dysfunction, and damage of neural network \[[@B50], [@B76]\]. Specifically, the excitotoxicity might be modulated by calcium-dependent receptors internalization mediated by TRP ion channels. Thus, TRP expression and function might stimulate cell protection and regeneration on oxidative-stressed tissues \[[@B93], [@B51]\].

The transmission of electrical signals from neuron to neuron in complex networks and circuits is central to brain function. Cultured neural stem/progenitors may differentiate into neurons as a consequence of external neural activity \[[@B20]\]. This activity-dependent neurogenesis requires calcium channels in others, in proliferating stem/progenitor cells. Control of proliferation, survival, and connection on the brain network in neural precursors is key to obtain "excitation-neurogenesis coupling" \[[@B34]\], a perfect merge of the stem cell-derived newborn neurons with the remaining neurons in the brain. Thus, the controlled activation of TRPV1 might offer an innovative strategy to cover all these important aspects of well-functioning neural precursors.

7. Perspectives: Control of Neural Stem Cells through TRPV1 {#sec7}
===========================================================

In the last years new techniques have been developed to monitor the activity of neural and nonneuronal cells remotely controlling ionic channels. The activation of specific cells through ionic channels triggers gene expression and peptide release*in vivo*. This constitutes a valuable research tool and a novel strategy for controlling cellular activity through regulated protein expression with potential applications in clinical settings.

The control of ionic channels depends on their biophysical properties as gating, desensitization, or allosteric coupling \[[@B39], [@B100]\]. These properties may be perturbed using chemicals ligands, voltage and light activation (optogenetics), physical modulation by temperature in specific points, or even magnetic fields \[[@B29], [@B37]--[@B82]\]. Some of these mechanisms are more convenient than others; chemical drug use is the simplest but the interaction with the entire organism in*in vivo* experiments leads to secondary effects or nonspecific results. On the other hand, the control of complex networks in animals through electrical or optical methods is technically challenging, because the depth of the tissues strongly attenuates electrical fields and light emission \[[@B37]\]. Magnetic fields were described as a specific remote control method because they have good penetration in biological tissues due to weak interaction with biological molecules \[[@B37], [@B82]\]. This weak interaction implies that in cells the magnetic fields have to be converted into a different stimulus such as aggregation of particles or mechanical force to act on their targets. One of the most common uses is the coupling of metal nanoparticles to ionic channels; these nanoparticles absorb energy and heat in response to radiofrequencies \[[@B82]--[@B74]\]. Using a temperature-sensitive channel, the heating can be converted into a cellular signal to allow ion influx and control of cellular functions \[[@B82]\].

TRPV1 have been used to control specific functions in neuronal and nonneuronal context in culture and in behaving animals \[[@B3], [@B29], [@B100], [@B21], [@B87]\]. In pancreas, a modified TRPV1 with antibody-coated iron oxide nanoparticles has been used as a temperature sensor that gates calcium to stimulate synthesis and release of bioengineered insulin via a promoter sensitive to calcium when heated in a low-frequency magnetic field \[[@B82]\]. This is particularly interesting because radio waves can be used to remotely activate insulin secretion by heating both externally applied and endogenously synthesized nanoparticles. Nowadays it is possible to generate cells with the ability to produce nanoparticles and of being controlled by TRPV1 activation, at least in nonneural context. However, the selective TRPV1 expression-mediated activation of neurons has shown to produce fast activity onset and consequent behavioral responses that depend on the specified neural population \[[@B29]\]. A paradigm of control where TRPV1-induced neural activity reached peaks within 7 minutes lasted only 10 minutes and was repeated immediately, stimulating brain plasticity through neurotransmitter release of dopaminergic or serotonergic neurons in freely moving mice \[[@B29]\].

Theoretically, selective control of stem cells could be exploited to investigate mechanistic pathways of excitation-neurogenesis coupling \[[@B35]\]. The development of functional TRPV1 channels in our stem cells-derived neurons or in neural precursors may provide a strategy to remotely control the survival, differentiation, and plasticity of these cells.

Imagine there is a new regeneration medicine of stem cells with genetically modified low radiofrequency-sensitive TRPV1 channels to control the survival and integration of stem cells grafts in the human brain.
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![Diagram of regions involved in TRPV1 function. (a) The primary structure involves six transmembrane segments (S1--S6) with a pore domain between the fifth (S5) and sixth (S6) segment, and both C and N termini are located intracellularly. The functional TRPV1 receptor is believed to form a homotetramer. Amino acid residues involved in the binding of chemical and physical activation/modulation of TRPV1 activity are indicated in a color scheme. Vanilloid compounds, as the activators capsaicin and resiniferatoxin, as well as inhibitor capsazepine share the same binding site, while cholesterol-binding site is composed of a promiscuous hydrophobic pocket in S5. (b) Model for hydrophobic pocket in S5 linker with the binding of lipidic molecules such as cholesterol (chol), PIP~2~, and capsaicin (CAP) generated by molecular dynamics. In this binding conformation, all the molecules occupy a groove formed between S5 and C-terminal of the subunit.](NP2016-1568145.001){#fig1}

![TRPV1 detected by immunofluorescence. (a) Methodology proposed for detection of TRPV1 by immunofluorescence. Using two antibodies against different epitopes of the channel allows corroborating the expression of the channel. In this case, we showed an antibody against the C-terminal and another against the N-terminal. As both antibodies bind to intracellular epitopes, it is advisable to use as internal control of the technique a sample without permeabilization of the plasma membrane, which prevents the entry of the antibody into the cell. One added strategy to improve signal sensitivity was the use of a blocking peptide, in this case, for the C-terminal or N-terminal. The competition of the blocking peptide with the epitope of the channel should diminish the intensity of the signal indicating the specificity of the technique. (b) Detection of TRPV1 in heterologous expression system using antibodies against the N-terminal and C-terminal of TRPV1. (c) Detection of TRPV1 in primate prefrontal cortex, using an antibody against the N-terminal and another against the C-terminal.](NP2016-1568145.002){#fig2}

![Expression of TRPV1 in neuronal differentiation process derived from LYON-ES. Determination of expression of TRPV1 by immunofluorescence staining for undifferentiated monkey ESCs stably expressing Tau-GFP (TAU-GFP LYON-ES1 line, a--d), NSCs (NS, e--h), neurons (i--l), and glial cells (m--p) derived from TAU-GFP-LYON-ES1 cells. At each stage, we performed immunofluorescence with antibodies against Oct4 (c) to identify LYON-ESCs, Pax6 for NSCs (g), *β*-III-tubulin for neurons (k), glial fibrillary acid protein (GFAP) for glial cells (o), and TRPV1 (d, h, l, p). Each experiment was accompanied by nuclear staining with DAPI (a, e, i, m), all the cells having a GFP fused to the microtubule-associated protein tau (b, f, j, n). The magnification of images was 20x for LYON-ESCs and neurons, and 40x for NSCs and glia cells.](NP2016-1568145.003){#fig3}
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